{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:11:54Z","timestamp":1781763114761,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.healun.2017.05.007","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T02:47:29Z","timestamp":1494038849000},"page":"948-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Perioperative statin use is associated with decreased incidence of primary graft dysfunction after lung transplantation"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0396-9928","authenticated-orcid":false,"given":"Jacob","family":"Raphael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Scalzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Kozower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel E.","family":"Durieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal S.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2017.05.007_bib1","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.healun.2004.11.049","article-title":"Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation","volume":"24","author":"Christie","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.05.007_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00134-006-0096-7","article-title":"Risk factors for reperfusion injury after lung transplantation","volume":"32","author":"Cottini","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.healun.2017.05.007_bib3","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1164\/rccm.200409-1243OC","article-title":"The effect of primary graft dysfunction on survival after lung transplantation","volume":"171","author":"Christie","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2017.05.007_bib4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1378\/chest.06-2752","article-title":"Early trends in PaO(2)\/fraction of inspired oxygen ratio predict outcome in lung transplant recipients with severe primary graft dysfunction","volume":"132","author":"Prekker","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.healun.2017.05.007_bib5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.healun.2007.07.018","article-title":"Primary graft dysfunction and long-term pulmonary function after lung transplantation","volume":"26","author":"Whitson","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.05.007_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0030-1249111","article-title":"Primary graft dysfunction: definition, risk factors, short- and long-term outcomes","volume":"31","author":"Lee","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.healun.2017.05.007_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1164\/rccm.200608-1079OC","article-title":"Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome","volume":"175","author":"Daud","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2017.05.007_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/rccm.201210-1865OC","article-title":"Clinical risk factors for primary graft dysfunction after lung transplantation","volume":"187","author":"Diamond","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2017.05.007_bib9","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.healun.2005.02.017","article-title":"Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers","volume":"24","author":"de Perrot","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.05.007_bib10","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.healun.2005.02.019","article-title":"Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: recipient-related risk factors and markers","volume":"24","author":"Barr","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.05.007_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1634\/theoncologist.11-3-306","article-title":"The role of statins in cancer therapy","volume":"11","author":"Hindler","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.healun.2017.05.007_bib12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00210-016-1252-4","article-title":"Pleiotropic effects of statins: new therapeutic targets in drug design","volume":"389","author":"Bedi","year":"2016","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.healun.2017.05.007_bib13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1097\/00000542-200612000-00027","article-title":"Improved postoperative outcomes associated with preoperative statin therapy","volume":"105","author":"Hindler","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.healun.2017.05.007_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/eurheartj\/ehv456","article-title":"Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study","volume":"37","author":"Berwanger","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2017.05.007_bib15","doi-asserted-by":"crossref","first-page":"II45","DOI":"10.1161\/01.CIR.0000138316.24048.08","article-title":"Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery","volume":"110","author":"Pan","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.05.007_bib16","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJMoa0808207","article-title":"Fluvastatin and perioperative events in patients undergoing vascular surgery","volume":"361","author":"Schouten","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2017.05.007_bib17","doi-asserted-by":"crossref","first-page":"e38917","DOI":"10.1371\/journal.pone.0038917","article-title":"Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation","volume":"7","author":"Grommes","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.healun.2017.05.007_bib18","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4187\/respcare.00770","article-title":"Long-term simvastatin attenuates lung injury and oxidative stress in murine acute lung injury models induced by oleic acid and endotoxin","volume":"56","author":"Altintas","year":"2011","journal-title":"Respir Care"},{"key":"10.1016\/j.healun.2017.05.007_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00134-009-1421-8","article-title":"Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury","volume":"35","author":"Kor","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.healun.2017.05.007_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1164\/rccm.201003-0423OC","article-title":"A randomized clinical trial of hydroxymethylglutaryl-coenzyme a reductase inhibition for acute lung injury (The HARP Study)","volume":"183","author":"Craig","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2017.05.007_bib21","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome","volume":"370","author":"Truwit","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2017.05.007_bib22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1164\/rccm.200205-410OC","article-title":"Statin use is associated with improved function and survival of lung allografts","volume":"167","author":"Johnson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2017.05.007_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/TP.0b013e318225670d","article-title":"Graft-protective effects of the HMG-CoA reductase inhibitor pravastatin after lung transplantation\u2014a propensity score analysis with 23 years of follow-up","volume":"92","author":"Li","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2017.05.007_bib24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1213\/ANE.0000000000001163","article-title":"Increased intraoperative fluid administration is associated with severe primary graft dysfunction after lung transplantation","volume":"122","author":"Geube","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1016\/j.healun.2017.05.007_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.healun.2010.08.024","article-title":"Impact of lung transplantation on serum lipids in adults with cystic fibrosis","volume":"30","author":"Nash","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.05.007_bib26","doi-asserted-by":"crossref","first-page":"E237","DOI":"10.1111\/ctr.12098","article-title":"Early development of metabolic syndrome in patients subjected to lung transplantation","volume":"27","author":"Savioli","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2017.05.007_bib27","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"Simvastatin in the acute respiratory distress syndrome","volume":"371","author":"McAuley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2017.05.007_bib28","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2017.05.007_bib29","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2017.05.007_bib30","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.0000037520.89770.5E","article-title":"Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction","volume":"106","author":"Herrmann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.05.007_bib31","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/ajt.12283","article-title":"Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation","volume":"13","author":"Cantu","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2017.05.007_bib32","doi-asserted-by":"crossref","first-page":"L528","DOI":"10.1152\/ajplung.2000.279.3.L528","article-title":"Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-kappaB","volume":"279","author":"Ross","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2017.05.007_bib33","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0003-4975(00)01425-9","article-title":"Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation","volume":"69","author":"King","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2017.05.007_bib34","doi-asserted-by":"crossref","first-page":"L69","DOI":"10.1152\/ajplung.00205.2013","article-title":"NADPH oxidase mediates synergistic effects of IL-17 and TNF-alpha on CXCL1 expression by epithelial cells after lung ischemia-reperfusion","volume":"306","author":"Sharma","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2017.05.007_bib35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jtcvs.2014.09.077","article-title":"Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation","volume":"149","author":"Cantu","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2017.05.007_bib36","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1164\/rccm.201506-1253OC","article-title":"NOX2 activation of natural killer T cells is blocked by the adenosine A2A receptor to inhibit lung ischemia-reperfusion injury","volume":"193","author":"Sharma","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2017.05.007_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/thx.2007.094540","article-title":"Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung","volume":"64","author":"Imamura","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2017.05.007_bib38","doi-asserted-by":"crossref","first-page":"L575","DOI":"10.1152\/ajplung.00428.2007","article-title":"Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition","volume":"295","author":"Chen","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2017.05.007_bib39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-5223(03)00699-8","article-title":"Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion","volume":"126","author":"Naidu","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2017.05.007_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.molonc.2011.11.003","article-title":"Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production","volume":"6","author":"Chen","year":"2012","journal-title":"Mol Oncol"},{"key":"10.1016\/j.healun.2017.05.007_bib41","doi-asserted-by":"crossref","first-page":"L592","DOI":"10.1152\/ajplung.00386.2007","article-title":"Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients","volume":"294","author":"Murphy","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2017.05.007_bib42","doi-asserted-by":"crossref","first-page":"H1918","DOI":"10.1152\/ajpheart.00416.2007","article-title":"The central role of adenosine in statin-induced ERK1\/2, Akt, and eNOS phosphorylation","volume":"293","author":"Merla","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.healun.2017.05.007_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10557-007-6036-0","article-title":"The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation","volume":"21","author":"Manickavasagam","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.healun.2017.05.007_bib44","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jtcvs.2010.03.002","article-title":"Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury","volume":"140","author":"Gazoni","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2017.05.007_bib45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jtcvs.2009.08.033","article-title":"Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury","volume":"139","author":"Sharma","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2017.05.007_bib46","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1097\/TP.0000000000000830","article-title":"Ex vivo perfusion with adenosine A2A receptor agonist enhances rehabilitation of murine donor lungs after circulatory death","volume":"99","author":"Stone","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2017.05.007_bib47","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jtcvs.2011.06.015","article-title":"Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model","volume":"142","author":"LaPar","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2017.05.007_bib48","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1046\/j.1538-7836.2003.00412.x","article-title":"Effects of statins on adhesion molecule expression in endothelial cells","volume":"1","author":"Dimitrova","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.healun.2017.05.007_bib49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1160\/TH03-04-0249","article-title":"Statins as novel immunomodulators: from cell to potential clinical benefit","volume":"90","author":"Mach","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.healun.2017.05.007_bib50","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1164\/rccm.201007-1173OC","article-title":"Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury","volume":"183","author":"Sharma","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2017.05.007_bib51","doi-asserted-by":"crossref","first-page":"762506","DOI":"10.1155\/2015\/762506","article-title":"Statins increase the frequency of circulating CD4+ FOXP3+ regulatory T cells in healthy individuals","volume":"2015","author":"Rodriguez-Perea","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.healun.2017.05.007_bib52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.carpath.2014.09.001","article-title":"Simvastatin combined with aspirin increases the survival time of heart allograft by activating CD4(+)CD25(+) Treg cells and enhancing vascular endothelial cell protection","volume":"24","author":"Zhu","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.healun.2017.05.007_bib53","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/TP.0000000000000526","article-title":"The critical role of induced CD4+ FoxP3+ regulatory cells in suppression of interleukin-17 production and attenuation of mouse orthotopic lung allograft rejection","volume":"99","author":"Zhou","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2017.05.007_bib54","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00595-011-0087-3","article-title":"Lung function early after lung transplantation is correlated with the frequency of regulatory T cells","volume":"42","author":"Nakagiri","year":"2012","journal-title":"Surg Today"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249817317837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249817317837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:33:41Z","timestamp":1760949221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249817317837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1053249817317837"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2017.05.007","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative statin use is associated with decreased incidence of primary graft dysfunction after lung transplantation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2017.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}